nach oben

Neurotoxicity Research

Erschienen in:

01.11.2012

Aβ Oligomers-Induced Toxicity is Attenuated in Cells Cultured with NbActiv4™ Medium

verfasst von: Yan Zhou, William L. Klein

Erschienen in: Neurotoxicity Research | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Pathogenic Aβ-derived diffusible ligands (ADDLs) bind to post-synaptic targets, induce excessive reactive oxygen species (ROS) and stimulate tau hyperphosphorylation in cultured neurons. Recently, NbActiv4™ medium was reported to increase neuron synapse densities in cultured hippocampal neurons. We aimed to investigate the effect of this novel medium on ADDL-induced toxicity. We found that ADDL-induced ROS was attenuated in cells cultured with NbActiv4™. ADDL binding assay was performed in neurons cultured by different feeding conditions with NbActiv4™. Feeding cells with 30 % medium once a week, ADDL binding sites were abundant at days in vitro (DIV) 18. However, changing 50 % medium once a week decreased ADDL binding about 80 %. NbActiv4™ produced about 40 % more glial fibrillary acidic protein (GFAP) positive astrocytes than the widely used hippocampal culture medium, neurobasal supplemented with B27 (neurobasal/B27). Astrocytes are reported to produce kinds of trophic factors including insulin-like growth factor 1 (IGF-1). Consistently, when cultured with NbActiv4™, neurons were sensitive to inhibitors of insulin/IGF-1 signaling in response to ADDL attack. Overall, this study supports the important role of astrocytes in neuroprotection and indicates that targeting astrocytes dysfunction may lead to new therapeutic strategies for Alzheimer’s disease.

Abramov AY, Canevari L et al (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 23(12):5088–5095PubMed

Abramov AY, Canevari L et al (2004) Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 1742(1–3):81–87PubMedCrossRef

Adhihetty PJ, Beal MF (2008) Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromolecular Med 10(4):275–290PubMedCrossRef

Brewer GJ, Boehler MD et al (2008) NbActiv4 medium improvement to Neurobasal/B27 increases neuron synapse densities and network spike rates on multielectrode arrays. J Neurosci Methods 170(2):181–187PubMedCrossRef

Brewer GJ, Boehler MD et al (2009) Chronic electrical stimulation of cultured hippocampal networks increases spontaneous spike rates. J Neurosci Methods 184(1):104–109PubMedCrossRef

Brinton RD (2008) The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci 31(10):529–537PubMedCrossRef

Carbonaro V, Caraci F et al (2009) Enhanced expression of ERalpha in astrocytes modifies the response of cortical neurons to beta-amyloid toxicity. Neurobiol Dis 33(3):415–421PubMedCrossRef

Chen JX, Yan SD (2007) Amyloid-beta-induced mitochondrial dysfunction. J Alzheimers Dis 12(2):177–184PubMed

Chromy BA, Nowak RJ et al (2003) Self-assembly of Abeta(1–42) into globular neurotoxins. Biochemistry 42(44):12749–12760PubMedCrossRef

De Felice FG, Velasco PT et al (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282(15):11590–11601PubMedCrossRef

De Felice FG, Wu D et al (2008) Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. Neurobiol Aging 29(9):1334–1347PubMedCrossRef

De Felice FG, Vieira MN et al (2009) Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA 106(6):1971–1976PubMedCrossRef

De Keyser J, Mostert JP et al (2008) Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J Neurol Sci 267(1–2):3–16PubMedCrossRef

Elmariah SB, Crumling MA et al (2004) Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses. J Neurosci 24(10):2380–2393PubMedCrossRef

Eng LF, Ghirnikar RS et al (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem Res 25(9–10):1439–1451PubMedCrossRef

Gong Y, Chang L et al (2003) Alzheimer’s disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100(18):10417–10422PubMedCrossRef

Hamilton NB, Attwell D (2010) Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 11(4): 227–238PubMedCrossRef

Houstis N, Rosen ED et al (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440(7086):944–948PubMedCrossRef

Kennedy SG, Kandel ES et al (1999) Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol 19(8):5800–5810PubMed

Kessler JA (1987) Deficiency of a cholinergic differentiating factor in fibroblasts of patients with Alzheimer’s disease. Ann Neurol 21(1):95–98PubMedCrossRef

Klein WL (2006) Synaptic targeting by Abeta oligomers (ADDLS) as a basis for memory loss in early Alzheimer’s disease. Alzheimers Dement 2(1):43–55PubMedCrossRef

Klein WL, Felice FD et al (2008) Why Alzheimer’s is a disease of memory: synaptic targeting by pathogenic Aβ oligomers (ADDLs). In: Selkoe DJ, Triller A, Christen Y (eds) Synaptic plasticity and the mechanism of Alzheimer’s disease. Springer, Berlin, Heidelberg, pp 103–132CrossRef

Lacor PN, Buniel MC et al (2004) Synaptic targeting by Alzheimer’s-related amyloid beta oligomers. J Neurosci 24(45):10191–10200PubMedCrossRef

Lacor PN, Buniel MC et al (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27(4):796–807PubMedCrossRef

Lambert MP, Barlow AK et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95(11):6448–6453PubMedCrossRef

Lambert MP, Viola KL et al (2001) Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem 79(3): 595–605PubMedCrossRef

Lambert MP, Velasco PT et al (2007) Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem 100(1):23–35PubMedCrossRef

Lesne S, Koh MT et al (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352–357PubMedCrossRef

Oberheim NA, Wang X et al (2006) Astrocytic complexity distinguishes the human brain. Trends Neurosci 29(10):547–553PubMedCrossRef

Parker WD Jr, Parks JK (1995) Cytochrome c oxidase in Alzheimer’s disease brain: purification and characterization. Neurology 45(3 Pt 1):482–486PubMedCrossRef

Parker WD Jr, Filley CM et al (1990) Cytochrome oxidase deficiency in Alzheimer’s disease. Neurology 40(8):1302–1303PubMedCrossRef

Parrizas M, Gazit A et al (1997) Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138(4):1427–1433PubMedCrossRef

Rodriguez JJ, Olabarria M et al (2009) Astroglia in dementia and Alzheimer’s disease. Cell Death Differ 16(3):378–385PubMedCrossRef

Rusinol AE, Thewke D et al (2004) AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J Biol Chem 279(2):1392–1399PubMedCrossRef

Sanchez C, Diaz-Nido J et al (1995) Variations in in vivo phosphorylation at the proline-rich domain of the microtubule-associated protein 2 (MAP2) during rat brain development. Biochem J 306(Pt 2):481–487PubMed

Senitz D, Reichenbach A et al (1995) Surface complexity of human neocortical astrocytic cells: changes with development, aging, and dementia. J Hirnforsch 36(4):531–537PubMed

Seth P, Koul N (2008) Astrocyte, the star avatar: redefined. J Biosci 33(3):405–421PubMedCrossRef

Shughrue PJ, Acton PJ et al (2008) Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons. Neurobiol Aging 32(2):189–202

Simakova O, Arispe NJ (2007) The cell-selective neurotoxicity of the Alzheimer’s Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity. J Neurosci 27(50):13719–13729PubMedCrossRef

Simpkins JW, Yi KD et al (2010) Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta 1800(10):1113–1120PubMedCrossRef

Tomiyama T, Matsuyama S et al (2010) A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J Neurosci 30(14):4845–4856PubMedCrossRef

Wurtman RJ (1985) Alzheimer’s disease. Sci Am 252(1): 62–66, 71–74

Zhao WQ, De Felice FG et al (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22(1):246–260PubMedCrossRef

Zhao WQ, Lacor PN et al (2009) Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. J Biol Chem 284(28):18742–18753PubMedCrossRef

Titel: Aβ Oligomers-Induced Toxicity is Attenuated in Cells Cultured with NbActiv4™ Medium
verfasst von: Yan Zhou
William L. Klein
Publikationsdatum: 01.11.2012
Verlag: Springer-Verlag
Erschienen in: Neurotoxicity Research / Ausgabe 4/2012
Print ISSN: 1029-8428
Elektronische ISSN: 1476-3524
DOI: https://doi.org/10.1007/s12640-012-9318-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Targeting Neuro-Inflammatory Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-Induced Huntington’s Disease-Like Symptoms in Rats

Cholinergic Dysfunctions and Enhanced Oxidative Stress in the Neurobehavioral Toxicity of Lambda-Cyhalothrin in Developing Rats

Efficacy and Safety of Long-term Botulinum Toxin Treatment in Craniocervical Dystonia: A Systematic Review

Cypermethrin Alters the Expression Profile of mRNAs in the Adult Rat Striatum: A Putative Mechanism of Postnatal Pre-exposure Followed by Adulthood Re-exposure-Enhanced Neurodegeneration

Z-Ligustilide Potentiates the Cytotoxicity of Dopamine in Rat Dopaminergic PC12 Cells

Nitric Oxide-Mediated Oxidative Damage and the Progressive Demise of Motor Neurons in ALS